STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

Cancer treatment is becoming increasingly personalised and oncologists know their enemy in more intimate detail than ever ...

Supporters who mistakenly thought a new law eliminated a costly barrier to breast cancer diagnostic screening in cancer-prone Iowa feel misled.

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

A friend of mine was recently diagnosed with a melanoma, an aggressive form of skin cancer that had spread throughout their ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

Results from the Phase III EMBARK trial show that in combination with leuprolide, Xtandi (enzalutamide) demonstrated a ...

The Central Texas Cancer Survivor Party, part of Cattle Baron’s Ball, will be held at 5:30 p.m. July 22 at the Texas Sports ...